Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019
Clinical trial NCT03016533 · COMPLETED
Trial details
- NCT number
- NCT03016533
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-06
- Primary completion
- 2024-12-24
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.